跳至主要内容
临床试验/NCT03576027
NCT03576027Unknown不适用

Evaluation of the Effectiveness of Hyperbaric Oxygen Therapy in the Treatment of Inflammatory Bowel Disease in Children

Medical University of Warsaw2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年5月21日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
Change of the ulcerative colitis activity

研究概览

简要总结

The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of inflammatory bowel disease in children.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of Crohn's disease or ulcerative colitis according to the criteria from Porto - based on the clinical condition as well as imaging and endoscopic examinations with histopathological assessment;
  • failure to achieve the remission despite the use of standard treatment in accordance with international guidelines;
  • written consent of the patient's legal guardians and the patient himself if he/she turns 16 years of age.

排除标准

  • intolerance of enclosed spaces;
  • contraindications for hyperbaric therapy: otolaryngological (otitis media, sinusitis); cardiac (clinically significant defects or arrhythmias); pneumological (clinically significant defects)
  • exacerbation of inflammatory bowel disease during the therapy;
  • contraindications for hyperbaric therapy in a patient's caregiver in a situation, where the patient requires his/hers presence inside the hyperbaric chamber during the session.

结局指标

主要结局

Change of the ulcerative colitis activity

时间窗: 40 days

Change in the disease activity based on the Paediatric Ulcerative Colitis Activity Index (PUCAI) for patients with ulcerative colitis.

Change of the Crohn's disease activity

时间窗: 40 days

Change in the disease activity based on the Pediatric Crohn's Disease Activity Index (PCDAI) for patients with Crohn's disease.

次要结局

  • Concentration of proinflammatory cytokines(40 days)
  • Number of participants with treatment-related adverse events(40 days)
  • Maintaining remission of the ulcerative colitis(1 year)
  • Maintaining remission of the Crohn's disease(1 year)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lukasz Dembinski

Principal Investigator

Medical University of Warsaw

研究点 (2)

Loading locations...

相似试验

Hyperbaric Oxygen Therapy in Children With... | 临床试验